The Impact of COVID-19 on the HIV Care Continuum in a Large Urban Southern Clinic.
COVID-19
Care continuum
HIV
Mental health
Journal
AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
accepted:
05
02
2022
pubmed:
24
2
2022
medline:
7
7
2022
entrez:
23
2
2022
Statut:
ppublish
Résumé
Access to care is essential for people with HIV (PWH) but may have been affected during the COVID-19 pandemic. We conducted a retrospective cross-sectional study of adult PWH receiving care in a large southeastern comprehensive care clinic in the United States. Patients in care between January 1, 2017, and July 30, 2020, were included. Race/ethnicity, sex, HIV-1 RNA, CD4 + lymphocyte count were included as baseline covariates. Outcomes included clinic attendance, receipt of HIV-1 RNA PCR testing, and virologic suppression (HIV-1 RNA < 200 copies/mL); outpatient encounters included new patient encounters, follow-up visits, and mental health encounters. Total medical encounters, including telemedicine, decreased by 827 visits (33%) when comparing the second quarters of 2019 and 2020. New patient encounters decreased by 23.5% from 81 to 62 during this period. The second quarter of 2020 saw the lowest number of new patient visits since 2017. HIV-1 RNA testing and the proportion of patients with virologic suppression decreased during the pandemic (p < 0.001 for both). Total mental health encounters, on the other hand, increased by 14% during April-June 2020 compared to April-June 2019. Mental health electronic communications increased by 60% from 312 to 500 during the same period, with a 20% increase in medication refills. The COVID-19 pandemic affected outpatient visits, viral load surveillance, and virologic suppression but led to an increase in mental health encounters in a comprehensive care clinic setting.
Identifiants
pubmed: 35194699
doi: 10.1007/s10461-022-03615-7
pii: 10.1007/s10461-022-03615-7
pmc: PMC8863570
doi:
Substances chimiques
RNA
63231-63-0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2825-2829Subventions
Organisme : NIAID NIH HHS
ID : K01 AI131895
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL156759
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI110527
Pays : United States
Organisme : NHLBI NIH HHS
ID : R25 HL145817
Pays : United States
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
WHO | Novel Coronavirus – China. WHO. http://www.who.int.proxy.library.vanderbilt.edu/csr/don/12-january-2020-novel-coronavirus-china/en/ (2020). Accessed 20 Aug 2020.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. https://doi.org/10.1016/S0140-6736(20)30183-5 .
doi: 10.1016/S0140-6736(20)30183-5
pubmed: 31986264
pmcid: 7159299
Patel JA, Nielsen FBH, Badiani AA, et al. Poverty, inequality and COVID-19: the forgotten vulnerable. Public Health. 2020;183:110–1. https://doi.org/10.1016/j.puhe.2020.05.006 .
doi: 10.1016/j.puhe.2020.05.006
pubmed: 32502699
Czeisler MÉ. Delay or avoidance of medical care because of COVID-19–related concerns—United States. MMWR Morb Mortal Wkly Rep. 2020;69:1250. https://doi.org/10.15585/mmwr.mm6936a4 .
doi: 10.15585/mmwr.mm6936a4
pubmed: 32915166
pmcid: 7499838
Yancy CW. COVID-19 and African Americans. JAMA. 2020;323(19):1891–2. https://doi.org/10.1001/jama.2020.6548 .
doi: 10.1001/jama.2020.6548
pubmed: 32293639
Hooper MW, Nápoles AM, Pérez-Stable EJ. COVID-19 and racial/ethnic disparities. JAMA. 2020;323(24):2466–7. https://doi.org/10.1001/jama.2020.8598 .
doi: 10.1001/jama.2020.8598
Bradley H, Hall HI, Wolitski RJ, et al. Vital signs: HIV diagnosis, care, and treatment among persons living with HIV—United States, 2011. MMWR Morb Mortal Wkly Rep. 2014;63(47):1113–7.
pubmed: 25426654
pmcid: 5779517
Ulett KB, Willig JH, Lin H-Y, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS. 2009;23(1):41–9. https://doi.org/10.1089/apc.2008.0132 .
doi: 10.1089/apc.2008.0132
pubmed: 19055408
pmcid: 2733237
Coronavirus Disease 2019 (COVID-19) Frequently Asked Questions. HIV/AIDS Bureau. https://hab.hrsa.gov/coronavirus/frequently-asked-questions . (2020). Accessed 28 Sept 2020.
Budak JZ, Scott JD, Dhanireddy S, Wood BR. The impact of COVID-19 on HIV care provided via telemedicine-past, present, and future. Curr HIV/AIDS Rep. 2021;18(2):98–104. https://doi.org/10.1007/s11904-021-00543-4 .
doi: 10.1007/s11904-021-00543-4
pubmed: 33616811
pmcid: 7898490
WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls. https://www.who.int/news-room/detail/06-07-2020-who-access-to-hiv-medicines-severely-impacted-by-covid-19-as-aids-response-stalls . (2020). Accessed 11 Aug 2020.
Giroir BP. The time is now to end the HIV epidemic. Am J Public Health. 2020;110(1):22–4. https://doi.org/10.2105/AJPH.2019.305380 .
doi: 10.2105/AJPH.2019.305380
pubmed: 31725312
pmcid: 6893354
HIV by Race/Ethnicity | HIV/AIDS | CDC. Published November 14, 2019. https://www.cdc.gov/hiv/group/racialethnic/index.html . (2020). Accessed 11 Aug 2020.
Economically Disadvantaged | HIV by Group | HIV/AIDS | CDC. Published December 11, 2019. https://www.cdc.gov/hiv/group/poverty.html . (2020). Accessed 11 Aug 2020.
Lesosky M, Myer L. Modelling the impact of COVID-19 on HIV. Lancet HIV. 2020;7:e596. https://doi.org/10.1016/S2352-3018(20)30228-9 .
doi: 10.1016/S2352-3018(20)30228-9
pubmed: 32771090
Mitchell KM, Dimitrov D, Silhol R, et al. The potential effect of COVID-19-related disruptions on HIV incidence and HIV-related mortality among men who have sex with men in the USA: a modelling study. Lancet HIV. 2021;8(4):e206–15. https://doi.org/10.1016/S2352-3018(21)00022-9 .
doi: 10.1016/S2352-3018(21)00022-9
pubmed: 33617783
pmcid: 8045548
Bienvenu LA, Noonan J, Wang X, Peter K. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities. Cardiovasc Res. 2020;116(14):2197–206. https://doi.org/10.1093/cvr/cvaa284 .
doi: 10.1093/cvr/cvaa284
pubmed: 33063089
Grau LE, Brothers S, Kim JY, Khwaja A, Heimer R, Stopka TJ. The HIV care continuum in small cities of Southern New England: perspectives of people living with HIV/AIDS, public health experts, and HIV service providers. AIDS Behav. 2021;25(3):897–907. https://doi.org/10.1007/s10461-020-03049-z .
doi: 10.1007/s10461-020-03049-z
pubmed: 33001353
Uthman OA, Magidson JF, Safren SA, Nachega JB. Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis. Curr HIV/AIDS Rep. 2014;11(3):291–307. https://doi.org/10.1007/s11904-014-0220-1 .
doi: 10.1007/s11904-014-0220-1
pubmed: 25038748
pmcid: 4359613
The need for standardisation of the HIV continuum of care - ClinicalKey. https://www-clinicalkey-com.proxy.library.vanderbilt.edu/#!/content/playContent/1-s2.0-S2352301815000867?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2352301815000867%3Fshowall%3Dtrue&referrer=https:%2F%2Fpubmed.ncbi.nlm.nih.gov%2F . (2021). Accessed 4 Oct 2021.
Qiao S, Li Z, Weissman S, et al. Disparity in HIV service interruption in the outbreak of COVID-19 in South Carolina. AIDS Behav. 2020;25:49. https://doi.org/10.1007/s10461-020-03013-x .
doi: 10.1007/s10461-020-03013-x
pmcid: 7453068
Ridgway JP, Schmitt J, Friedman E, et al. HIV care continuum and COVID-19 outcomes among people living with HIV during the COVID-19 pandemic, Chicago, IL. AIDS Behav. 2020;24:2770. https://doi.org/10.1007/s10461-020-02905-2 .
doi: 10.1007/s10461-020-02905-2
pubmed: 32382823
pmcid: 7203502
Delivering HIV Care Prevention in the COVID Era A National Survey of Ryan White Providers – Issue Brief – 9596 | KFF. https://www.kff.org/report-section/delivering-hiv-care-prevention-in-the-covid-era-a-national-survey-of-ryan-white-providers-issue-brief/ . (2021). Accessed 4 Oct 2021.
Mugavero MJ, Raper JL, Reif S, et al. Overload: the impact of incident stressful events on antiretroviral medication adherence and virologic failure in a longitudinal multi-site HIV cohort study. Psychosom Med. 2009;71(9):920–6. https://doi.org/10.1097/PSY.0b013e3181bfe8d2 .
doi: 10.1097/PSY.0b013e3181bfe8d2
pubmed: 19875634
pmcid: 3691857
Whetten K, Reif S, Whetten R, Murphy-McMillan LK. Trauma, mental health, distrust, and stigma among HIV-positive persons: implications for effective care. Psychosom Med. 2008;70(5):531–8. https://doi.org/10.1097/PSY.0b013e31817749dc .
doi: 10.1097/PSY.0b013e31817749dc
pubmed: 18541904
Pfefferbaum B, North CS. Mental health and the covid-19 pandemic. N Engl J Med. 2020;383(6):510–2. https://doi.org/10.1056/NEJMp2008017 .
doi: 10.1056/NEJMp2008017
pubmed: 32283003
Sanchez TH, Zlotorzynska M, Rai M, Baral SD. Characterizing the impact of COVID-19 on men who have sex with men across the United States in April, 2020. AIDS Behav. 2020;24(7):2024–32. https://doi.org/10.1007/s10461-020-02894-2 .
doi: 10.1007/s10461-020-02894-2
pubmed: 32350773
pmcid: 7189633
DECLINE IN HIV TESTING AND CHANGES IN POSITIVITY RATES DURING THE COVID-19 PANDEMIC. https://www.natap.org/2021/IAS/IAS_109.htm . (2021). Accessed 14 Oct 2021.